| 今开：1.53 | 昨收：1.5 |
| 最高：1.58 | 最低：1.38 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.9073509E7 |
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-01 03:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006036 Act: 34 Size: 13 KB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-060021 Size: 8 KB 网页链接
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-060022 Size: 8 KB 网页链接
$Cue生物制药(CUE)$ 内部交易: 2021-10-01,CHIEF FINANCIAL OFFICER,Millar Kerri-Ann ,卖出,1251普通股, $14.21
$Cue生物制药(CUE)$ 内部交易: 2021-10-01,CHIEF FINANCIAL OFFICER,Millar Kerri-Ann ,期权,1251普通股, $7.50
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-059698 Size: 14 KB 网页链接
$Cue生物制药(CUE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-289860 Act: 33 Size: 324 KB 网页链接
$Cue生物制药(CUE)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-21-289829 Act: 34 Size: 418 KB 网页链接
$Cue生物制药(CUE)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-289821 Act: 33 Size: 10 KB 网页链接
$Cue生物制药(CUE)$ 内部交易: 2021-09-24,CHIEF EXECUTIVE OFFICER,PASSERI DANIEL R ,买入,3400普通股, $14.72
$Cue生物制药(CUE)$ 内部交易: 2021-09-23,PRESIDENT AND CSO,Suri Anish ,卖出,20000普通股, $15.23